|
Catalog Number 500101 |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
|
Patient Problems
Death (1802); Liver Damage/Dysfunction (1954); Neurological Deficit/Dysfunction (1982); Renal Failure (2041)
|
Event Type
Death
|
Manufacturer Narrative
|
Investigation summary: with a review of the available information, there is no evidence of a device malfunction or performance issues that would impact the reported events.Possible clinical factors that may have contributed to this event include the patients pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulants, antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to this event.This device is used for treatment, not diagnosis.The syncardia 70cc temporary total artificial heart (tah-t) is an implantable pulsatile biventricular replacement device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation systems.The syncardia 70cc tah-t is indicated for use as a bridge to transplantation in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure.The syncardia tah-t system is intended for use inside and outside the hospital.This event was assessed and is being reported as part of a retrospective review of events in response to an update to the mdr complaint sources.If new or additional information is received in the future, syncardia will file a follow-up mdr.(b)(4).
|
|
Event Description
|
A retrospective review of intermacs de-identified data collected between september 22, 2015 and september 30, 2017 revealed that a patient expired with a cause of death listed as nervous system: neurological dysfunction.The intermacs data listed that the tah-t functioned normally.The intermacs data listed that the tah-t was not explanted.
|
|
Manufacturer Narrative
|
(b)(4) follow-up report 1.
|
|
Event Description
|
While supported by the tah-t for 12 days, the patient experienced the following adverse events as defined by intermacs: two (2) days post implant - renal dysfunction.Three (3) days post implant - bleeding.Eight (8) days post implant - hepatic dysfunction.Eleven (11) days post implant - neurological dysfunction - cva/location: right hemisphere: frontal, right hemisphere: parietal, right hemisphere: temporal, right hemisphere: unspecified/severity: altered mental status.
|
|
Search Alerts/Recalls
|
|
|